Neil Goldfarb, president and CEO of the Greater Philadelphia Business Coalition on Health (GPBCH), reviews the key topics to be addressed at the 2022 GPBCH Wellness Summit.
The 2022 Greater Philadelphia Business Coalition on Health (GPBCH) Wellness Summit, taking place on September 13 in Mount Laurel, New Jersey, will provide audience members with novel ideas and strategies on key issues related to employee health and well-being, as well as how they can support advancement of community and public health, said Neil Goldfarb, president and CEO of the GPBCH.
Transcript
Can you discuss the theme of the 2022 GPBCH Wellness Summit?
Our theme this year for our annual Wellness Summit is advancing equity for both physical and mental health. What we are doing is covering a fairly broad array of topics in employee health and well-being, but in each of those topic sessions, we will hit on what employers can do to increase equity as they try to increase well-being for the general population.
So, we have sessions on topics like obesity, building cultures of health, advancing mental health, advancing community health, the future of vaccines and how employers can promote vaccines to the appropriate population. And in all of those conversations, we're going to be talking about general strategies but also hitting on health equity and how it relates to that topic, what employers can do to really advance health in an equitable manner.
What lessons do you hope audience members gain from the meeting?
With all of our conferences, we want people to come away with new ideas and new strategies. We prefer that our sessions not be confirmatory, meaning telling you what you already knew. It's really how to look at something in a different manner or how to really make progress on something that we already identify as an issue.
A good example is obesity. Every employer I speak with recognizes that obesity is a significant driver of morbidity, mortality, and cost. So, the question is not to talk about, does obesity impact those things, but it's really what can you as an employer do to equitably advance prevention, advance treatment, and support employees who have the disease of obesity.
So we want people to come away with new ways of looking at a problem, new strategies for addressing the problem, ideas for how to evaluate the success or lack of success of their efforts, and basically give people hope that progress can be made—that they're in the ideal position to not only improve the health of their own population, but to contribute to community and public health. We want people to feel inspired by the speakers, not feel like they're overwhelmed, and we want to hear within the months after the program that some people actually implemented things differently to try to advance health.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More